Japan Pressure Ulcer Care Dressing Market Size, Share, By Dressing Type (Antimicrobial Dressing, Foam Dressings, Film Dressings, Alginate Dressings, Hydrocolloid Dressings, Collagen Coatings,and Others) By Purchase Mode (Prescription Medications and No Prescription) By End Users (Hospital Settings, Outpatient Facilities, Home Care, Community Health Centers, and Nursing Homes) Japan Pressure Ulcer Care Dressing Market Industry Trend, Forecasts to 2035.
Industry: HealthcareJapan Pressure Ulcer Care Dressing Market Insights Forecasts to 2035
- Japan Pressure Ulcer Care Dressing Market Size 2024: USD 131.78 Million
- Japan Pressure Ulcer Care Dressing Market Size 2035: USD 281.21 Million
- Japan Pressure Ulcer Care Dressing Market CAGR 2024: 7.13%
- Japan Pressure Ulcer Care Dressing Market Segments: Dressing Type, Purchase Mode, and End Use.

Get more details on this report -
The Japan pressure ulcer care dressing market refers to the industry focused on products used to prevent and treat pressure ulcers, also known as bedsores. These dressings include foam, hydrocolloid, hydrogel, alginate, and antimicrobial products designed to protect wounds, promote healing, and reduce infection risk, mainly for elderly, immobile, or hospitalised patients. Furthermore, the Japan pressure ulcer care dressing market is growing, among other factors, due to the growth of the elderly population, the rise of pressure ulcer patients, and an increase in hospitalisation rates. There is greater product adoption of advanced wound care products, with improved infrastructure and strong reimbursement support, driven by a growing demand for home healthcare, increased awareness of the prevention of pressure ulcers, and developments related to innovations in dressing materials.
The Japan government provides support in terms of wound care management through universal healthcare coverage, including reimbursement services for advanced dressing products. The Japanese government offers support in terms of long-term care insurance programs, which provide support to elderly patients who need wound management. In addition, healthcare system reforms related to elderly care and hospital infection control help promote pressure ulcer wound care products.
Japan pressure ulcer care dressing market trends include increasing adoption of advanced foam and antimicrobial dressings, rising home healthcare use, and integration of infection-prevention technologies. There is a growing preference for moisture-retentive and easy-to-apply products. Hospitals are focusing on preventive care to reduce ulcer incidence. Digital wound monitoring and patient-centred treatment approaches are also gaining attention.
Market Dynamics of the Japan Pressure Ulcer Care Dressing Market:
The Japan pressure ulcer care dressing market is driven by the growing ageing population, a rising number of bedridden patients, and the increasing number of chronic diseases like diabetes. The increase in the number of long-term care facilities and home health services also contributes to the market. The awareness of the potential of advanced wound management and the development of new technology in antimicrobial and foam dressings also drives the market.
Restraints of the Japan pressure ulcer care dressing market: In the Japan pressure ulcer care dressing market, cost factors related to high-end products act as a restraint. For pressure ulcer treatment, advanced dressing products are considered to offer better results, and as a result, a significant number of healthcare facilities in Japan might find these products expensive. In the pressure ulcer care segment, trained caregivers are also a major restraint for the Japanese dressing market. Furthermore, in terms of growth prospects, the population of Japan is slowing down.
The Japan pressure ulcer care dressing market offers opportunities for growth in the Japanese pressure ulcer care dressings market. These include the development of cost-effective, sophisticated dressings and growth prospects for home healthcare. There is also innovation and partnership opportunities of antimicrobial and bioactive dressings, which is seen as having enormous growth potential. In addition, awareness and development of sophisticated wound monitoring systems also portray growth prospects.
Japan Pressure Ulcer Care Dressing Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 131.78 Million |
| Forecast Period: | 2024-2035 |
| Forecast Period CAGR 2024-2035 : | CAGR of 7.13 % |
| 2035 Value Projection: | USD 281.21 Million |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 210 |
| Tables, Charts & Figures: | 90 |
| Segments covered: | By Dressing Type |
| Companies covered:: | , 3M Company, B. Braun SE, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group PLC, Integra Lifesciences, Medtronic, Molnlycke Health Care, Paul Hartmann AG, Smith & Nephew, and other key players |
| Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Market Segmentation
The Japan pressure ulcer care dressing market share is classified into dressing type, purchase mode, and end use.
By Dressing Type:
The Japan pressure ulcer care dressing market is divided by dressing type into antimicrobial dressings, foam dressings, film dressings, alginate dressings, hydrocolloid dressings, collagen coatings, and others. Among these, the foam dressings segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The foam dressings systems segment dominates due to their high absorbency, cushioning, infection protection, and suitability for moderate to severe pressure ulcers, making them widely preferred in hospitals and long-term care facilities.
By Purchase Mode:
The Japan pressure ulcer care dressing market is divided by purchase mode into prescription medications and non-prescription. Among these, the prescription medications segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The prescription medications segment dominates because hospitals and long-term care facilities require professional medical supervision, regulatory compliance, and tailored treatment plans to ensure safe and effective management of pressure ulcers.
By End Use:
The Japan pressure ulcer care dressing market is divided by end use into hospital settings, outpatient facilities, home care, community health centres, and nursing homes. Among these, the hospital settings segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The hospital settings dominate because hospitals manage the highest number of bedridden, elderly, and critically ill patients who are at greater risk of pressure ulcers. Continuous monitoring, advanced wound care facilities, skilled medical staff, and access to prescription dressings make hospitals the primary end-use segment driving market demand.
Competitive Analysis:
The report offers the appropriate analysis of the key organisations/companies involved within the Japan pressure ulcer care dressing market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Key Companies in Japan Pressure Ulcer Care Dressing Market:
- 3M Company
- B. Braun SE
- Cardinal Health, Inc.
- Coloplast A/S
- ConvaTec Group PLC
- Integra Lifesciences
- Medtronic
- Molnlycke Health Care
- Paul Hartmann AG
- Smith & Nephew
- Other
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan pressure ulcer care dressing market based on the below-mentioned segments:
Japan Pressure Ulcer Care Dressing Market, By Dressing Type.
- Antimicrobial Dressing
- Foam Dressings
- Film Dressings
- Alginate Dressings
- Hydrocolloid Dressings
- Collagen Coatings
- Others
Japan Pressure Ulcer Care Dressing Market, By Purchase Mode
- Prescription Medications
- No Prescription
Japan Pressure Ulcer Care Dressing Market, by End Use.
- hospital settings
- outpatient facilities
- home care
- community health centres
- nursing homes
Frequently Asked Questions (FAQ)
-
What is the Japan pressure ulcer care dressing market size? Japan pressure ulcer care dressing market is expected to grow from USD 131.78 million in 2024 to USD 281.21 million by 2035, growing at a CAGR of 7.13 % during the forecast period 2025-2035.
-
What are the key growth drivers of the Japan pressure ulcer care dressing market? Japan pressure ulcer care dressing market is a growth driver of Japan’s pressure ulcer care dressing market, include aging population, increasing pressure ulcer prevalence, chronic diseases, advanced wound care technologies, home healthcare demand, and favourable reimbursement policies.
-
What factors restrain the Japan pressure ulcer care dressing market? The Japan pressure ulcer care dressing market is restrained by high product costs, strict regulatory approvals, limited reimbursement, caregiver shortages, low adoption in smaller facilities, and slowing population growth
-
How is the Japan pressure ulcer care dressing market segmented by purchase mode? The Japan pressure ulcer care dressing market is segmented into prescription medications and non-prescription.
-
Who are the key players in the Japan pressure ulcer care dressing market?Key companies operating in the Japan pressure ulcer care dressing market include 3M Company, B. Braun SE, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group PLC, Integra Lifesciences, Medtronic, Molnlycke Health Care, Paul Hartmann AG, Smith & Nephew, and others.
Need help to buy this report?